Identification of novel phosphoproteomic biomarkers in patients with advanced hepatocellular carcinoma (HCC)

被引：0
|
作者：
Sarker, Debashis
Pedicona, Federico
Zen, Yoh
Borek, Weronika E.
Khorsandi, Shirin Elizabeth
Christopher, Josie
Karampera, Christina
Dowe, Thomas
Heaton, Nigel
Cutillas, Pedro Rodriguez
Dokal, Arran David
Britton, David James
机构：
[1] Kings Coll London, London, England
[2] Kinom Ltd, Macclesfield, Cheshire, England
[3] Kings Coll Hosp London, London, England
[4] Kings Coll Hosp London, Inst Liver Studies, London, England
[5] Kings Coll Hosp London, London, England
[6] Queen Mary Univ London, Barts Canc Inst, London, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15155
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma
    Zhuang, Hongkai
    Chen, Bo
    Tang, Chenwei
    Chen, Xinming
    Tan, Wenliang
    Yang, Lei
    Xie, Zhiqin
    Ma, Xiaowu
    Wang, Qingbin
    Zhang, Chuanzhao
    Shang, Changzhen
    Chen, Yajin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma
    Yang, Bo
    Zhao, Yonghui
    Wang, Lan
    Zhao, Yuanyuan
    Wei, Lai
    Chen, Dong
    Chen, Zhishui
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [43] Identification of novel serum biomarkers of hepatocellular carcinoma using glycomic analysis
    Kamiyama, Toshiya
    Yokoo, Hideki
    Furukawa, Jun-Ichi
    Kurogochi, Masaki
    Togashi, Tomoaki
    Miura, Nobuaki
    Nakanishi, Kazuaki
    Kamachi, Hirofumi
    Kakisaka, Tatsuhiko
    Tsuruga, Yosuke
    Fujiyoshi, Masato
    Taketomi, Akinobu
    Nishimura, Shin-Ichiro
    Todo, Satoru
    HEPATOLOGY, 2013, 57 (06) : 2314 - 2325
  • [44] Identification and verification of novel ferroptosis biomarkers predicts the prognosis of hepatocellular carcinoma
    Wu, Siqian
    Liu, Meiliang
    Xiao, Suyang
    Lai, Mingshuang
    Wei, Liling
    Li, Deyuan
    Wang, Lijun
    Yin, Fuqiang
    Zeng, Xiaoyun
    GENOMICS, 2023, 115 (06)
  • [45] Candidates for Surveillance for Hepatocellular Carcinoma (HCC) Among Patients with Advanced Cirrhosis in the United States
    Flemming, Jennifer A.
    Kim, W. Ray
    Stock, Peter
    Terrault, Norah
    HEPATOLOGY, 2012, 56 : 1091A - 1091A
  • [46] Nivolumab (Nivo) in Patients (Pts) With Advanced Hepatocellular Carcinoma (HCC): the CheckMate 040 Study
    Melero, Ignacio
    Sangro, Bruno
    Yau, Thomas
    Hsu, Chiun
    Kudo, Masatoshi
    Crocenzi, Todd S.
    Kim, Tae-You
    Choo, Su-pin
    Trojan, Jorg
    Meyer, Timothy
    Welling, Theodore
    Yeo, Winnie
    Chopra, Akhil
    Anderson, Jeffrey
    Delacruz, Christine
    Lang, Lixin
    Neely, Jaclyn
    Tang, Hao
    El-Khoueiry, Anthony B.
    HEPATOLOGY, 2016, 64 (06) : 1124A - 1124A
  • [47] Early toxicity of sunitinib as a potential predictive biomarker in advanced hepatocellular carcinoma (HCC) patients
    Duda, G. D.
    Ancukiewicz, M.
    Clark, J. W.
    Miksad, R. A.
    Fuchs, C.
    Ryan, D. P.
    Jain, R. K.
    Zhu, A. X.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [48] Concomitant use of antiacids in patients with advanced hepatocellular carcinoma (HCC) receiving sorafenib therapy
    Razak, Razwan Abd
    Kunene, Victoria
    Ma, Yuk Ting
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [49] Phase I study of everolimus in combination with sorafenib in patients with advanced hepatocellular carcinoma (HCC).
    Finn, R. S.
    Poon, R. T. P.
    Yau, T.
    Klumpen, H.
    Chen, L.
    Kang, Y.
    Kim, T.
    Gomez-Martin, C.
    Rodriguez-Lope, C.
    Kunz, T.
    Paquet, T.
    Asubonteng, K.
    Winkler, R. E.
    Anak, O.
    Sellami, D. B.
    Bruix, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [50] Early experience of combination treatment of sorafenib and radiotherapy in patients with advanced hepatocellular carcinoma (HCC)
    Seong, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
12345